"This Hypertension, Diabetes and Dyslipidemia conference will offer critical information about the latest updates for these diseases. With so many guidelines to track, all healthcare clinicians should attend." --Jan Basile, MD-Program Chair
Palm Coast, Florida (PRWEB) February 10, 2015
In collaboration with the Carolinas, Georgia, Florida Chapter of the American Society of Hypertension, Continuing Education Company Inc. is pleased to offer the 19th Annual Conference on Hypertension, Diabetes and Dyslipidemia. This three-day intensive conference will be held on June 26-28, 2015 at the Charleston Marriott in downtown Charleston, South Carolina and has been endorsed by the American Society of Hypertension and The Southeast Lipid Association.
Healthcare Professionals attending the conference may choose to lengthen their stay by attending the 6th Annual Essentials in Primary Care Summer I which will take place June 29-July 3 at nearby Kiawah Island Resort. Kiawah and its beautiful beaches are just a 40-minute drive away. Special combination pricing is available as well as one day pricing.
This activity is designed for clinicians specializing in Internal Medicine, Family or General Practice, Geriatric Medicine, Endocrinology, Lipidology and Hypertension Specialists. Healthcare professionals including physicians, physician assistants and nurse practitioners specializing in these areas or those managing patients with Hypertension, Diabetes, and/or Hyperlipidemia, alone or in combination, may benefit from this activity. Each day concludes with cases to help illustrate points made during the earlier presentations.
This conference will address issues confronting the clinician who treats patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to transport these clinical principles back to their every day practice to improve patient care. Controversial topics will be addressed such as the guidelines on the levels of LDL cholesterol and blood pressure as well as the ACCORD, VADT, and ADVANCE studies which suggest the benefits on reducing macrovascular disease events are unclear.
The objectives of the 19th Annual Hypertension, Diabetes and Dyslipidemia Conference include discussing goals, medications, treatment plans, how to apply new learning to improve health outcomes and many other topics.
Jan Basile, MD-Program Chair says, "This Hypertension, Diabetes and Dyslipidemia conference will offer critical information about the latest updates for these diseases. With so many guidelines to track, all healthcare clinicians should attend."
For more information about the conference, visit the company's website http://www.cmemeeting.org